Another marijuana-based drug, nabiximols (Sativex), is available in Canada and several European countries to treat multiple sclerosis and spasticity in patients with multiple sclerosis.
Medicinal cannabis is unlikely to be a new treatment. It was widely used as a patented drug in the United States in the early 19th and 20th centuries, was listed on the US Pharmacopoeia until the Marijuana Tax Act of 1937 made it illegal.
Then, in 1970, federal law made it Sc Schedule 1 control, which severely restricted the entry of marijuana for legal testing. Complicating matters with medical evidence is the fact that marijuana-like plants contain hundreds of active chemicals, the amounts of which can vary greatly. As long as researchers have not been able to study simple amounts of refined materials, the conclusions about the benefits and risks are highly unreliable.
According to Dr. Finney’s book, here are some conclusions that experts have reached about the role of medical marijuana in their respective fields.
Pain avi management
People who use marijuana for pain relief do not reduce their dependence on opioids. In fact, Dr. Finn said: “Patients who use marijuana for pain still report having a pain level of 10 on a scale of 1 to 10.” The authors of the chapter on pain avi, Dr. Peter R. Wilson, an analyst at Rochester Mayo Clinic և Dr. Sanjog Pangarkar of VA Health in Los Angeles, concluded: “Cannabis itself does not cause analgesia; paradoxically it can interfere with opioid analgesia.” 2019 A study of 450 adults in the journal Addiction Medicine found that medical marijuana not only failed to alleviate patients’ pain but also increased their risk of anxiety, depression and substance abuse.
Dr. Allen S. Bowling, a neurologist at the NeuroHealth Institute in Englewood, Colo, said that while marijuana was widely studied as a treatment for multiple sclerosis, the results of randomized clinical trials were inconsistent. “Trials in general have shown some but limited efficacy. In one of the longest and longest trials, the placebo performed better in treating spasticity, pain, and bladder dysfunction,” said Dr. Bowling. Most of the experiments used pharmaceutical-grade cannabis, which is not available at the dispensary.
Research shows that marijuana can reduce the risk of glaucoma since the 1970s. Indeed, THC is lower than the harmful pressure inside the eye, but as Dr. Finney T., an ophthalmologist at the University of Oklahoma Center for Health Sciences. John on և Jean an R. Haus wrote: “To treat glaucoma, to reach the therapeutic level of marijuana in the blood, one needs to smoke six to eight times a day,” he said. Major eye care companies have put their fingers on marijuana to treat glaucoma.
Alison Carst, a psychiatric pharmacist at Tennessee Health Service in Tennessee who studied the benefits and risks of medical marijuana, concluded that marijuana can have a “negative effect on mental health and neurological function,” including PTSD and other symptoms.
Dr. Karst also cited another study that found that only 17 percent of edible hemp products were accurately labeled. He wrote in the e-mail that the lack of regulation “makes it difficult to export evidence of different products available in the consumer market, given the differences in chemical composition and purity.” He warned the public to consider the “potential benefits and risks” to which I would add Beware of the buyer – Beware of the buyer.